A journalist with dual Russian and US citizenship faces as much as five years in prison after being detained in Russia and charged with failing to register as a “foreign agent,” her employer said Thursday.
UK Prime Minister Rishi Sunak embarked on a round of high-stakes Middle East diplomacy with an echo of Britain’s wartime leader Winston Churchill, saying that Israel is facing “its darkest hour” and telling Israeli premier Benjamin Netanyahu: “We want you to win.”
UK Prime Minister Rishi Sunak underlined Britain’s support for Israel by saying “we want you to win,” as part of a broader diplomatic push to contain the conflict with Hamas and provide vital humanitarian supplies to Gaza.
Walgreens Boots Alliance Inc. agreed to pay $192.5 million to resolve investor claims that some of the drugstore chain’s executives misled them about its 2015 bid to acquire rival Rite Aid Corp.
American Airlines Group Inc. topped Wall Street’s expectations for third-quarter profit even as its forecast for the rest of the year fell short, underscoring the choppy environment as carriers are battered by climbing jet fuel prices.
Depository Trust & Clearing Corp. agreed to buy startup Securrency Inc, part of the main US stock-market clearinghouse’s drive to offer blockchain technology and services for functions like post-trade processing of tokenized assets.
Deutsche Bank AG is expanding restrictions on its financing of coal, one of the main sources of energy in its home market of Germany, as part of a wider crackdown on high-emitting sectors.
Unesco denied that it cleared Zimbabwe and Zambia to proceed with the construction of a $5 billion hydropower dam downstream from the Victoria Falls, which it has designated as a World Heritage Site.
Peru is likely to exceed its fiscal deficit ceilings this year and next as public revenue falls short of expectations, according to the nation’s official budget watchdog.
Sanofi’s Lantus, its most commonly prescribed insulin, will sell for $35 a month through GoodRx Holdings Inc. in a deal that signals the drug-discount site’s growing business with large pharma companies.
